Nathan Boggs

Dr. Nathan Boggs is a Physician Scientist at the Uniformed Services University of the Health Sciences (USU) and Walter Reed National Military Medical Center. He specializes in Allergy and Immunology, focusing on systemic mastocytosis, inborn errors of immunity genetics, myeloid neoplasms, and allergy-related conditions. His work includes developing a clinical registry for systemic mastocytosis, improving genetic diagnostics, and leading the SUMMIT clinical trial for bezuclastinib in non-advanced mastocytosis cases.

• Allergy & Immunology Fellowship, National Institute of Allergy and Infectious Diseases (2019)
• Internal Medicine Residency, Yale-New Haven Hospital (2017)
• M.D., Uniformed Services University (2014)
• Ph.D. in Plant Molecular Biology, Cornell University (2009)
• B.S. in Plant & Soil Science, University of Vermont (2003)

Dr. Boggs’ research integrates clinical and genetic approaches to address systemic mastocytosis and related disorders. He utilizes whole genome and RNA sequencing to identify genetic underpinnings of diseases like urticaria and mastocytosis, aiming to enhance diagnostic accuracy and treatment efficacy. His work also explores mast cell disorders triggered by hymenoptera venom and the implications of fire ant anaphylaxis on military readiness.

Recent publications highlight collaborations with ARUP Labs and the NIH Clinical Center. The SUMMIT clinical trial for non-advanced systemic mastocytosis and his leadership in establishing Walter Reed as a Center of Excellence for mast cell diseases underscore his clinical and research impact. Dr. Boggs’ studies span dermatology, allergy, and immunology, emphasizing standardized evaluation protocols and innovative therapeutic strategies.

Dr. Boggs’ ongoing projects focus on improving care pathways for systemic mastocytosis patients through clinical registries and advanced diagnostics. His work bridges translational research, clinical practice, and military healthcare requirements, ensuring alignment with broader public health and medical technology advancements.